Christopher Gilmore

Christopher (Chris) E. Gilmore was named Aprecia Pharmaceutical LLC's Chief Executive Officer in April 2019 after extensive senior executive roles in sales, business development and corporate strategy in pharmaceutical and technology growth companies. For more than 30+ years in corporate leadership, he has been recognized with awards and promotions in sales, marketing, business strategy, global commercialization and M&A.

Miami University(OH) & Richard T. Farmer School of Business (Finance) graduate. This was his first book.